IGROV1 is an ovarian carcinoma cell line which was highly sensitive to dasatinib (log(GI50) = −8 in NCI-TPW, representing the highest possible sensitivity based on the screening range), and it showed a strong upregulation of HDAC5 by dasatinib (log2FC = 2.437 in NCI-TPW, baseline expression in untreated cells = 4.551 measured at 6 hr and 4.335 at 24 hr). Here, HDAC5 is linked to ovarian carcinoma.